Metabolic associated fatty liver disease and adverse maternal and fetal outcomes: a systematic review and meta-analysis

AIM OF THE STUDY: Metabolic-associated fatty liver disease (MAFLD) is now the most prevalent chronic liver disease in the world. Its prevalence in women of reproductive age is approximately 10%. Due to its high prevalence in this specific population, it is important to investigate adverse maternal a...

Descripción completa

Detalles Bibliográficos
Autores principales: Dyah, Adinda Ayu, Rahadina, Rahadina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2021
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8527343/
https://www.ncbi.nlm.nih.gov/pubmed/34712833
http://dx.doi.org/10.5114/ceh.2021.109228

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8527343/
https://www.ncbi.nlm.nih.gov/pubmed/34712833
http://dx.doi.org/10.5114/ceh.2021.109228

Ejemplares similares